These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29484537)

  • 1. Establishment of two basal-like breast cancer cell lines with extremely low tumorigenicity from Taiwanese premenopausal women.
    Kuo WL; Ueng SH; Wu CH; Lee LY; Lee YS; Yu MC; Chen SC; Yu CC; Tsai CN
    Hum Cell; 2018 Apr; 31(2):154-166. PubMed ID: 29484537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.
    Ihemelandu CU; Leffall LD; Dewitty RL; Naab TJ; Mezghebe HM; Makambi KH; Adams-Campbell L; Frederick WA
    J Surg Res; 2007 Nov; 143(1):109-18. PubMed ID: 17950079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating HR+/HER2- breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression.
    Yeo W; Ueno T; Lin CH; Liu Q; Lee KH; Leung R; Naito Y; Park YH; Im SA; Li H; Yap YS; Lu YS;
    Breast Cancer Res Treat; 2019 Oct; 177(3):549-559. PubMed ID: 31270763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft.
    Skrbo N; Hjortland GO; Kristian A; Holm R; Nord S; Prasmickaite L; Engebraaten O; Mælandsmo GM; Sørlie T; Andersen K
    PLoS One; 2014; 9(11):e113278. PubMed ID: 25419568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterisation of cell line models for triple-negative breast cancers.
    Grigoriadis A; Mackay A; Noel E; Wu PJ; Natrajan R; Frankum J; Reis-Filho JS; Tutt A
    BMC Genomics; 2012 Nov; 13():619. PubMed ID: 23151021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potential.
    Mosoyan G; Nagi C; Marukian S; Teixeira A; Simonian A; Resnick-Silverman L; DiFeo A; Johnston D; Reynolds SR; Roses DF; Mosoian A
    PLoS One; 2013; 8(1):e55145. PubMed ID: 23372829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYC amplification in subtypes of breast cancers in African American women.
    Naab TJ; Gautam A; Ricks-Santi L; Esnakula AK; Kanaan YM; DeWitty RL; Asgedom G; Makambi KH; Abawi M; Blancato JK
    BMC Cancer; 2018 Mar; 18(1):274. PubMed ID: 29523126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
    Carey LA; Perou CM; Livasy CA; Dressler LG; Cowan D; Conway K; Karaca G; Troester MA; Tse CK; Edmiston S; Deming SL; Geradts J; Cheang MC; Nielsen TO; Moorman PG; Earp HS; Millikan RC
    JAMA; 2006 Jun; 295(21):2492-502. PubMed ID: 16757721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of breast cancer subtypes by quantitative assessment of biological parameters: relationship with clinicopathological characteristics, biological features and prognosis.
    Del Casar JM; Martín A; García C; Corte MD; Alvarez A; Junquera S; González LO; Bongera M; García-Muñiz JL; Allende MT; Vizoso F
    Eur J Obstet Gynecol Reprod Biol; 2008 Dec; 141(2):147-52. PubMed ID: 18768247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between acquired uniparental disomy and homozygous mutations and HER2/ER/PR status in breast cancer.
    Tuna M; Smid M; Zhu D; Martens JW; Amos CI
    PLoS One; 2010 Nov; 5(11):e15094. PubMed ID: 21152100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of fatty acid binding protein-7 correlates with basal-like subtype of breast cancer.
    Tang XY; Umemura S; Tsukamoto H; Kumaki N; Tokuda Y; Osamura RY
    Pathol Res Pract; 2010 Feb; 206(2):98-101. PubMed ID: 19608352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer.
    Singel SM; Cornelius C; Batten K; Fasciani G; Wright WE; Lum L; Shay JW
    Clin Cancer Res; 2013 Apr; 19(8):2061-70. PubMed ID: 23479679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast Cancer.
    Liu XY; Ma D; Xu XE; Jin X; Yu KD; Jiang YZ; Shao ZM
    Theranostics; 2018; 8(22):6386-6399. PubMed ID: 30613307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IPH-926 lobular breast cancer cells are triple-negative but their microarray profile uncovers a luminal subtype.
    Christgen M; Geffers R; Kreipe H; Lehmann U
    Cancer Sci; 2013 Dec; 104(12):1726-30. PubMed ID: 24344720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice.
    Diaz LK; Cryns VL; Symmans WF; Sneige N
    Adv Anat Pathol; 2007 Nov; 14(6):419-30. PubMed ID: 18049131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ∆Np63/p40 correlates with the location and phenotype of basal/mesenchymal cancer stem-like cells in human ER
    Liu Y; Nekulova M; Nenutil R; Horakova I; Appleyard MV; Murray K; Holcakova J; Galoczova M; Quinlan P; Jordan LB; Purdie CA; Vojtesek B; Thompson AM; Coates PJ
    J Pathol Clin Res; 2020 Jan; 6(1):83-93. PubMed ID: 31591823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular subtypes of breast cancer emerging in young women in Taiwan: evidence for more than just westernization as a reason for the disease in Asia.
    Lin CH; Liau JY; Lu YS; Huang CS; Lee WC; Kuo KT; Shen YC; Kuo SH; Lan C; Liu JM; Kuo WH; Chang KJ; Cheng AL
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1807-14. PubMed ID: 19505913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of established risk factors with breast cancer subtypes.
    McCarthy AM; Friebel-Klingner T; Ehsan S; He W; Welch M; Chen J; Kontos D; Domchek SM; Conant EF; Semine A; Hughes K; Bardia A; Lehman C; Armstrong K
    Cancer Med; 2021 Sep; 10(18):6456-6467. PubMed ID: 34464510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
    Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
    Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.